Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
12/05/2025
According to the Financial Times: OpenAI is in talks with Microsoft to unlock new funds and a potential future IPO.
Latest
2 m ago
Hengguang Corporation: Termination of investment in the construction of a 270,000 ton annual production green electrochemical materials project.
2 m ago
The USD/JPY exchange rate touched 148 upwards, the first time since April 9, rising by 1.81% within the day.
3 m ago
Guangdong: Reduce the financing costs for manufacturing and high-tech enterprises, with a maximum annual interest subsidy amount of 20 million yuan for individual enterprises.
3 m ago
US pharmaceutical stocks fell across the board before the market opened, with Novonordisk falling 5.25%, AbbVie falling 4.12%, AstraZeneca falling 3.8%, Novartis falling 3.7%, and Gilead Sciences falling 3.46%. Trump announced plans to sign an executive order that will immediately lower drug prices by 30%-80%.
3 m ago
Pre-market trading in US pharmaceutical stocks saw a general decline, with Novo Nordisk (NVO.N) down 5.25%, AbbVie (ABBV.N) down 4.12%, AstraZeneca (AZN.O) down 3.8%, Novartis (NVS.N) down 3.7%, and Gilead Sciences (GILD.O) down 3.46%. Trump announced plans to sign an executive order to immediately lower drug prices by 30%-80%.
See all latest